Melanotan 2 10mg – Genopharm

Melanotan II functions as a synthetic analogue of alpha-melanocyte-stimulating hormone. It binds to MC1R receptors on melanocytes, triggering the production of melanin. Unlike selective agonists, MT-II also interacts with MC3R and MC4R receptors, which may explain its additional reported effects on appetite and sexual arousal. The compound is water-soluble and unstable when exposed to heat or light. Once reconstituted, the solution must be stored at 2-8°C to maintain peptide integrity. Users typically administer it via subcutaneous injection into the abdomen or thigh. The biological half-life is short, necessitating daily or twice-daily dosing to maintain receptor occupancy. Research indicates that consistent dosing over several weeks is required to observe significant changes in skin pigmentation.

Community protocols and user reports suggest that Melanotan II may enhance UV-induced tanning and increase overall skin pigmentation. Users often report a faster onset of tan with less sunburn sensitivity compared to untreated skin. Some anecdotal reports mention increased libido and appetite changes, likely due to the non-selective receptor binding. The tanning effect is cumulative, with users typically reporting visible changes after 2-4 weeks of consistent use. It is important to note that these effects are not guaranteed and vary significantly between individuals. The compound does not protect against UV damage, so sunscreen use remains critical to prevent skin cancer and photoaging. Users should document their baseline skin tone to accurately assess any changes over time.

Melanotan II is typically used as a standalone compound in research settings. It is not commonly stacked with anabolic steroids or SARMs, as its mechanism of action is distinct from androgenic pathways. Some users pair it with vitamin D3 and zinc supplements, which are theoretically involved in melanin synthesis, though clinical evidence for this synergy is limited. Avoid stacking with other melanocortin agonists, as this may increase the risk of side effects without additive benefit. If combining with other injectable peptides, ensure that the reconstitution process is sterile and that all compounds are stored separately to prevent cross-contamination. Do not mix MT-II with other solutions in the same syringe unless compatibility is verified. Always allow the tanning effect to stabilize before introducing new variables into your protocol.

Common side effects reported by users include nausea, flushing, and facial redness, particularly during the initial titration phase. Some individuals experience erectile dysfunction or priapism, which is a serious medical condition requiring immediate attention. Skin lesions or moles may become darker or change in appearance, necessitating regular dermatological checks. The compound is not approved for human use, and long-term safety data is lacking. Users should monitor for any unusual skin changes and discontinue use if adverse reactions occur. Refrigeration is mandatory after reconstitution to prevent peptide degradation. Do not use if you have a history of melanoma or other skin cancers. Consult a healthcare professional before initiating any peptide research protocol.

⚠️ Safety

• Discontinue use if you experience priapism or severe erectile dysfunction.
• Monitor skin moles for changes in size, color, or shape.
• Do not use if you have a history of melanoma or skin cancer.